DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
Precision Drilling
PDS
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.47%5.87B | 5.75%1.49B | 3.52%1.47B | 2.66%1.47B | 1.97%1.45B | -0.99%5.68B | -0.98%1.41B | -0.35%1.42B | -0.97%1.43B | -1.66%1.42B |
Operating revenue | 3.47%5.87B | 5.75%1.49B | 3.52%1.47B | 2.66%1.47B | 1.97%1.45B | -0.99%5.68B | -0.98%1.41B | -0.35%1.42B | -0.97%1.43B | -1.66%1.42B |
Cost of revenue | -0.71%2.11B | 4.71%534M | -1.28%538M | -2.27%516M | -3.69%522M | -2.03%2.13B | -3.04%510M | 0.18%545M | -3.30%528M | -1.99%542M |
Gross profit | 5.97%3.76B | 6.34%956M | 6.51%933M | 5.56%950M | 5.48%924M | -0.36%3.55B | 0.22%899M | -0.68%876M | 0.45%900M | -1.46%876M |
Operating expense | 10.05%3.29B | 10.61%834M | 9.79%819M | 9.46%833M | 10.34%800M | 3.93%2.99B | 0.53%754M | 5.22%746M | 8.71%761M | 1.54%725M |
Selling and administrative expenses | 4.80%1.73B | 6.31%421M | 5.43%427M | 4.91%449M | 2.64%428M | -5.67%1.65B | -12.39%396M | -6.03%405M | 0.23%428M | -4.14%417M |
Depreciation amortization depletion | 14.84%1.63B | 14.40%429M | 15.17%410M | 12.43%398M | 17.58%388M | 19.71%1.42B | 20.19%375M | 20.27%356M | 22.07%354M | 16.20%330M |
-Depreciation and amortization | 14.84%1.63B | 14.40%429M | 15.17%410M | 12.43%398M | 17.58%388M | 19.71%1.42B | 20.19%375M | 20.27%356M | 22.07%354M | 16.20%330M |
Other operating expenses | 14.67%-64M | 5.88%-16M | -20.00%-18M | 33.33%-14M | 27.27%-16M | -38.89%-75M | -21.43%-17M | 16.67%-15M | -23.53%-21M | -340.00%-22M |
Operating profit | -15.58%477M | -15.86%122M | -12.31%114M | -15.83%117M | -17.88%124M | -18.23%565M | -1.36%145M | -24.86%130M | -29.08%139M | -13.71%151M |
Net non-operating interest income expense | -27.92%-724M | -9.04%-181M | -23.65%-183M | -35.61%-179M | -50.83%-181M | -25.78%-566M | -40.68%-166M | -24.37%-148M | -17.86%-132M | -18.81%-120M |
Non-operating interest income | -8.05%80M | -18.52%22M | -9.09%20M | 17.65%20M | -14.29%18M | 107.14%87M | 50.00%27M | 37.50%22M | 183.33%17M | 950.00%21M |
Non-operating interest expense | 23.12%804M | 5.18%203M | 19.41%203M | 33.56%199M | 41.13%199M | 32.72%653M | 41.91%193M | 25.93%170M | 26.27%149M | 36.89%141M |
Other net income (expense) | -183.90%-99M | -156.00%-70M | -165.52%-19M | -677.78%-70M | 322.22%60M | -67.04%118M | 13.64%125M | -79.43%29M | -110.47%-9M | -228.57%-27M |
Special income (charges) | -69.86%-124M | -44.00%-36M | -75.00%-28M | -8.33%-26M | -325.00%-34M | 52.60%-73M | -56.25%-25M | 70.37%-16M | 20.00%-24M | 85.19%-8M |
-Less:Restructuring and merger&acquisition | 69.86%124M | 44.00%36M | 75.00%28M | 8.33%26M | 325.00%34M | -26.26%73M | 127.27%25M | 300.00%16M | -20.00%24M | -85.19%8M |
Other non- operating income (expenses) | -86.91%25M | -122.67%-34M | -80.00%9M | -393.33%-44M | 594.74%94M | -62.70%191M | 19.05%150M | -76.92%45M | -87.07%15M | -125.33%-19M |
Income before tax | -395.73%-346M | -224.04%-129M | -900.00%-88M | -6,500.00%-132M | -25.00%3M | -80.47%117M | -25.18%104M | -94.36%11M | -101.18%-2M | -95.79%4M |
Income tax | -127.27%-24M | -112.64%-11M | -6M | -9M | 100.00%2M | -44.30%88M | 643.75%87M | 0 | 0 | -96.67%1M |
Net income | -1,210.34%-322M | -794.12%-118M | -845.45%-82M | -6,050.00%-123M | -66.67%1M | -93.42%29M | -89.03%17M | -90.83%11M | -101.98%-2M | -95.38%3M |
Net income continuous Operations | -1,210.34%-322M | -794.12%-118M | -845.45%-82M | -6,050.00%-123M | -66.67%1M | -93.42%29M | -89.03%17M | -90.83%11M | -101.98%-2M | -95.38%3M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -1,210.34%-322M | -794.12%-118M | -845.45%-82M | -6,050.00%-123M | -66.67%1M | -93.42%29M | -89.03%17M | -90.83%11M | -101.98%-2M | -95.38%3M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | ||||||||
Net income attributable to common stockholders | -1,210.34%-322M | -794.12%-118M | -845.45%-82M | -6,050.00%-123M | -66.67%1M | -93.42%29M | -89.03%17M | -90.83%11M | -101.98%-2M | -95.38%3M |
Basic earnings per share | -1,183.33%-1.3 | -771.43%-0.47 | -760.00%-0.33 | -4,800.00%-0.49 | -59.40%0.0041 | -93.33%0.12 | -88.89%0.07 | -89.80%0.05 | -102.44%-0.01 | -96.30%0.01 |
Diluted earnings per share | -1,183.33%-1.3 | -771.43%-0.47 | -760.00%-0.33 | -4,800.00%-0.49 | -59.52%0.004 | -93.33%0.12 | -88.89%0.07 | -89.80%0.05 | -102.44%-0.01 | -96.15%0.01 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |